ecoa SOLUTIONS Eliminate ecoa complexity so you can move ahead quickly

Similar documents
BEST PRACTICES GUIDE COMPLYING WITH THE ICH E6(R2) ADDENDUM

Complete ecoa Solutions

HOW TO IMPLEMENT AN ecoa STRATEGY

BIOCLINICA CLINICAL DATA MANAGEMENT

Best Practices for Managing Clinical Research Information

MANAGING AND INTEGRATING CLINICAL TRIAL DATA: A Challenge for Pharma and their CRO Partners

THERAPEUTIC AREAS CARDIOVASCULAR RESEARCH

Reducing the Time to Market with an eclinical System

Leading Provider of Technology-Enabled Solutions for Clinical Research

Clinical Data in Business Intelligence

Getting Connected: The Benefits of a Unified Clinical Platform

Cardinal Health Specialty Solutions. Bringing a new drug to life. Regulatory Sciences

Selecting A Right Patient Recruitment Company: The Key To Success

Welcome. Thank you for joining us. Irina Moissiu, Director Client Relations Laurie Furiness, EVP Operations & Consulting Services

Smart research starts here.

THE EXPERT PRECISION QT APPROACH

inventivhealthclinical.com The Goal: Reducing Uncertainty A Word on RBM

Developing Drugs for Rare Diseases: Patient Advocacy s Perspective. Kristina Bowyer Executive Director, Patient Advocacy

End-to-End Management of Clinical Trials Data

SAS End-to-End solutions in Clinical Trial Emma Liu, SAS R&D, Beijing, China

INTRODUCTION TO MODERN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SERVICES

MEETING THE INCREASING REQUIREMENTS FOR HUMAN FACTORS CONSIDERATIONS

Case Study. What Successful eclinical Vendor Selection Looks Like: Linear Clinical Research Finds a Crucial Asset in Medrio EDC and esource

Why Industry Collaborations Matter TransCelerate BioPharma, Inc.

BEST PRACTICES FOR RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM)

EDC, esource, and epro.

11 Hidden Features of electronic Trial Master Files (etmfs) to Optimize the Value of Your etmf

Meeting sponsor s criteria : strategy to collaborate, engage and deliver

Central Monitoring by Data Management Edit checks, logical checks, automatic review of data, trend analyses

Intralinks Studyspace : Electronic Investigator-Controlled Site File (eisf)

What s New in GCP? FDA Draft Guidance Details FIH Multiple Cohort Trials

MCRA Clinical More Than Your Average CRO. Clinical Project Management. Site Management and Study Monitoring. Data Management. Auxiliary Services

Perspective: Convergence of CLIA and FDA Requirements A Rational Shift in the Regulatory Paradigm

MANAGING MATURE PRODUCT PORTFOLIOS - KEY CHALLENGES AND BENEFITS

BIOCLINICA SITE & PATIENT PAYMENTS

Anatomy of an FDA Audit Trigger Prevention and Process

Bracket ecoa. Bracket RTSM. and. An ebook on the Unique Platform Integration Capabilities of Bracket s ecoa and RTSM BRACKETGLOBAL.

Agilent OpenLAB Chromatography Data System COMPLIANCE AND EASE OF USE, TOGETHER AT LAST

PhlexEview: Transforming Costly Paper Processes into Value Driven Compliance

DRIVING CLINICAL DATA STANDARDS BEYOND COMPLIANCE

Best Practices for epro Implementation in Clinical Trials

Solving Data Management Problems Through Unified Solutions

WHAT ARE THE COMPONENTS OF ENSURING SENSORS AND WEARABLES ARE APPLIED CORRECTLY IN CLINICAL TRIALS?

The Case for ICH E6(R2) Compliance Assessment

SMART Technology. starts here. with CTM TECHNOLOGY WHERE IT COUNTS.

AQUA. Data-backed Assurance

Veeva 2018 Unified Clinical Operations Survey

A Full-Service International CRO. Risk-based Monitoring: What it Needs to Be. Phil Doren, Ph.D., Global Vice President, Biometrics

SMARTER DRUG DEVELOPMENT: TRANSFORMING YOUR CLINICAL OPERATING MODEL

Regulatory Requirements for Medical Devices in China

5-Minute Guide to. Cognitive Search for the Life Sciences

Smarter Healthcare across the Lifecycle with Analytics

IRT and EDC: The Unified Experience Integrating and streamlining complex processes to better clinical trials

XClinical Software & Services Fast - Flexible - Focused

SAS & Clinical Data Repository Karthikeyan Chidambaram

Solve for now. Build for next. The Deloitte Audit

Session 4: Statistical considerations in confirmatory clinical trials II

SOLVING THE PATIENT RECRUITMENT DILEMMA

What is content chaos? How can you outthink it?

Public release of clinical information in drug submissions and medical device applications

Veeva 2017 Unified Clinical Operations Survey

CDISC Journal. Current status and future scope of CDISC standards. By Rebecca D. Kush, President and CEO, CDISC. 1. Introduction

Putting CDISC Standards to Work How Converting to CDISC Standards Early in the Clinical Trial Process Will Make Your CDISC Investment Pay

Jefferies TMT Conference

FY18 Results Presentation 12 months to 30 June 2018

Adopting Site Quality Management to Optimize Risk-Based Monitoring

SAS Life Science Analytics Framework

EAUTIFUL BDATA AGGREGATION EXTRAVAGANZA. Implementing a Clinical Data Repository and Analytics Platform in 90 Days

Proven leadership, smart innovation, customer success B E N C H M A R K I N H E A LT H C A R E I T.

Everest Group PEAK Matrix Assessment for Life Sciences Clinical Trials Products

BIOMETRICS SERVICES ADVISORY DATA OFFICE UNBLINDING SECURE INDEPENDENT TEAM PROGRAM. ADaM TRAINER SAFETY SDTM COMPLIANT TA-EXPERTISE SDTM DATA

New Health Data Economy: Strategic Partnerships with Life Sciences Company

Perceptive MyTrials Product Overview

GLOBAL Trend and opportunities in drug development

IMARC Research, Inc. Executive Summary. Independent. Monitoring. Auditing. Research. Consulting WE LL EARN YOUR APPROVAL.

Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd.

The Promise and Challenge of Adaptive Design in Oncology Trials

RSNA/SNM/FDA. Management of Image Data Workflow. Two Topic Imaging Workshop: Standards for Imaging Endpoints in Clinical Trials

INNOVATIVE STATISTICAL DESIGN & ANALYSIS IN PD

How Data Managers Support Prospective Research

Overview and Frequently Asked Questions

Innovative approach to building an adaptive trial design in Medidata Rave

Project Delivery Excellence

Volunteering for Clinical Trials

confidence. High-quality pharmaceutical market research that enables confident tactical and strategic business decisions

TransCelerate A collaboration to find solutions to critical industry challenges

PAREXEL PARTNER PROGRAM. Broaden your reach with a partner you can trust

Longview 2017 Consolidation

Weighing the Impact of FDA Regulatory Uncertainty on Clinical Decision Support Development

Webinar: Knowledge-based approaches to decreasing clinical attrition rates

NEW AGILE CLINICAL TRIALS SUCH AS ADAPTIVE DESIGNS AND THE USE OF THE SAS LIFE SCIENCE ANALYTICAL FRAMEWORK

Risk-Based Monitoring - Prospective from CRO

How to Plan for a Successful Deployment

ICON plc Brendan Brennan CFO

Making Life Easier for Investigators: A Shared Solution for Smarter, Faster Clinical Trials

Implications for Investigator Initiated Trials (IITs)- Risk Based Approaches in Managing Clinical Trials

Marcia Brackman, Data Scientist Eli Lilly and Company

Transform Clinical Research Into Value-Based Personalized Care

INSIGHT-DRIVEN FORMULATIONS DEVELOPMENT

INTRODUCING CLINIC AUTOMATION IN A PHASE I UNIT WITH END-TO-END E-SOURCE DATA PROCESSING

Transcription:

ecoa SOLUTIONS Eliminate ecoa complexity so you can move ahead quickly

THE PROBLEM WITH COA The quality of collected patient data, study timelines and study costs are influenced by a number of factors, including: Complex protocols Larger sample sizes Data collection in multiple languages Different global regulations Mid-study protocol changes Paper-based data collection systems tend to be inefficient and error prone; therefore, managing these factors on paper is particularly challenging and further compromises data quality, patient safety and compound efficacy. In addition, compiling and reviewing disparate data can delay your database lock and submissions. Technological implementations are increasingly used to help manage study complexity. However, because of the multiple modalities needed to engage and retain diverse patient populations, the use of technology-based clinical outcome assessments (COA) can seem as inefficient as paper-based methods. 57% OF TRIALS UNDERGO PROTOCOL AMENDMENTS 1 ACCELERATE YOUR RESEARCH WITH ERT ecoa With electronic clinical outcome assessment (ecoa) technology, you can access data in real-time to view early and interim study results for regulatory review or to seek funding. But with so many solutions available, how do you know what s right for your trial? With our integrated ecoa solutions, you can accelerate your research with technology that doesn t get in the way. ERT DATA epro Visualize all your data EDC CTMS IVR PDF Export interim and final PDF archives SITE ARCHIVES SPONSOR ARCHIVES IMAGES WEARABLES MEDICAL DEVICES LABS ecoa Single database, single sign-on Facilitate data management Get trustworthy electronic data Routine data extracts for data cleaning & clarifications > Fewer miscoding errors and missing data > Protected data > Direct electronic connections minimize data tampering ERT ecoa ENVIRONMENT: TRULY UNDERSTAND IF THE THERAPY IS BOTH EFFICACIOUS AND SAFE Stay two steps ahead with 24/7 access to near real-time data, anticipate patient safety issues and address data quality concerns 1. Getz et al, Therapeutic Innovation & Regulatory Science 2016, Vol. 50(4) 436-441. http://dij.sagepub.com/content/50/4/436 Retrieved 4 December 2016

ELIMINATE ecoa COMPLEXITY SO YOU CAN MOVE AHEAD QUICKLY Not all ecoa technologies are created equal. We ve applied more than 20 years of scientific and technical experience collecting high-quality data for global clinical trials, providing electronic systems for more than half of all drug approvals since 2013. Be certain about trial design and execution Our ecoa scientists review every protocol to ensure maximum patient engagement and suitable content. Consistent design facilitates predictable data collection and more efficient study change management. Improve data quality and increase patient engagement You can easily collect data from diverse patient populations with our multi-modality capabilities. Collect patient data anywhere whether collecting data on a handheld, tablet, browser or bring-yourown-device (BYOD). Universal screen features and functions facilitate consistent and predictable data collection, avoiding study bias. Stop manually collating patient data from different sources With our ecoa, your study database can be integrated with medical devices, EDC, labs, IVR and other streams. You only need a single sign-on account for a comprehensive view of all patient data. Anticipate issues in near real time No more waiting until study close to understand what s been happening in your trial. Instead, audit study performance online 24/7 using near real time operational and clinical data reporting that s centralized. Heat mapping is available for patient/site enrollment, compliance & trending, visit schedules and device inventories for at-a-glance identification of problem areas. Streamline the submission process Our ecoa solutions provide two archives to meet regulatory needs a complete archive for each site and an archive with de-identified data for sponsors. Archives are in the required PDF submissible format, and contain all data and documentation necessary to recreate any trial for health authorities. Learn how you can accelerate your research with ecoa technology that doesn t get in the way. For more information, email sales@ert.com. 2100+ ecoa TRIALS 56 ecoa DRUG APPROVALS 120,000+ ecoa SITES 840,000+ ecoa PATIENTS 94 COUNTRIES SUPPORTED 106 LANGUAGES SUPPORTED

MINIMIZE RISK Rater training and gating Safeguard the standardized use of each instrument > > Interactive video and quiz training on-device or via web > > Training for patients, caregivers and clinicians > > Gating to link ecoa and rater training environments > > Fully configurable training platform adjustable to study needs Suicide risk assessment Electronic deployment of suicide risk assessment > > Integrate the C-SSRS and ec-ssrs, gold standard assessments for SIB > > Accelerated screening and identification of patients at risks > > Self-report enables detection of more severe events Anticipatory oversight Anticipate issues in near real-time with 24/7 access to data > > Centralized reporting oversight of all study data at your fingertips > > Predictive analytics based on relationships between patient data and lab and medical device data > > Alerts for patient safety Streamlined submission process Streamline submission process with full regulatory compliance > > Full compliance with global regulations > > Two archives to meet regulatory needs: a complete archive for each site and an archive with de-identified data for sponsors > > Archives in the required PDF-submissable format

HAVE CONFIDENCE AT EVERY TURN Scientific expertise paired with every protocol Our ecoa clinical scientists review every protocol > > Ensure fit-for-purpose study design > > Design practices proven to efficiently collect well-chosen endpoints > > Regulatory compliance and validated instrument design Patient and site engagement evidence Ensure optimal patient and site compliance > > Ongoing research to quantify patient preferences > > Best practices minimize patient burden and improve communications > > Site training via on-device and web-based workflows Consistent, standardized ecoa Migrate paper-based assessments, instrument development and validation > > Cognitive briefing and usability testing ensure content validity > > Assessments vetted through scientific focus groups > > Publication of repeatable, valid findings Study database integration Stop manually collecting and collating patient data from different sources > > Integrate study database with medical devices, EDC, labs, IVR and other streams > > Leverage universal screen features and functions for more standardized data > > Single sign-on for a comprehensive view of all patient data

ABOUT ERT ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials so that customers can move ahead with confidence. With more than 40 years of clinical and therapeutic experience, ERT balances knowledge of what works with a vision for what s next, so we can adapt without compromising standards. Powered by the company s EXPERT technology platform, ERT s solutions enhance trial oversight, enable site optimization, increase patient engagement, and measure the efficacy of new clinical treatments while ensuring patient safety. Over the past three years, more than half of all FDA drug approvals came from ERTsupported studies. Pharma companies, biotechs, and CROs have relied on ERT solutions in 9,000+ studies spanning three million patients to date. By identifying trial risks before they become problems, ERT enables customers to bring clinical treatments to patients quickly and with confidence. @ERTglobal @ERT @ERTglobal REV 14APR2017 2017 ERT. All rights reserved.